Craig Thompson, the CEO and president of the Memorial Sloan-Kettering Cancer Center, is being accused of taking research belonging to a University of Pennsylvania cancer institute and using it to start a pharmaceutical company, reports Pharmalot's Ed Silverman. The Abramson Family Cancer Research Institute at the University of Pennsylvania — where Thompson was a faculty member from 1999 until 2010 — says Thompson did not honor an agreement stating that any scientific discoveries made there belongs to the institute and thus has made $110 million so far from intellectual property that doesn't belong to him. "His work at the Institute involved developing a cancer metabolism research platform that was designed to examine the role that metabolic changes play in the origins, progression and death of cancer cells," Silverman says. "However, Thompson later co-founded Agios Pharmaceuticals, which was focused on researching cancer metabolism to develop new treatments." The institute says Thompson has caused about $1 billion in damages, and has included Agios in its lawsuit. Thompson did not comment to Silverman.
A Thief in the Night?
Dec 21, 2011